Financials Ainos, Inc.

Equities

AIMD

US00902F3038

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 10:33:01 2024-04-29 am EDT 5-day change 1st Jan Change
1.035 USD -0.49% Intraday chart for Ainos, Inc. +2.48% -49.51%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 10.52 12.06 6.993 119.7 12.41 8.32
Enterprise Value (EV) 1 9.758 12.1 7.924 121.5 11.82 12.13
P/E ratio -7.19 x -7.57 x -4.78 x -24.5 x -0.6 x -0.61 x
Yield - - - - - -
Capitalization / Revenue 135 x 1,028 x 422 x 201 x 3.53 x 68.1 x
EV / Revenue 126 x 1,031 x 478 x 204 x 3.36 x 99.3 x
EV / EBITDA -7.63 x -7.77 x -5.56 x -66.7 x -1.29 x -1.51 x
EV / FCF -7.2 x -23.8 x -14.3 x 4.66 x -0.48 x 12.8 x
FCF Yield -13.9% -4.19% -7.01% 21.4% -207% 7.82%
Price to Book 14.5 x -77.6 x -8.53 x 11.9 x 0.36 x 0.39 x
Nbr of stocks (in thousands) 520 536 548 1,899 4,002 4,059
Reference price 2 20.25 22.50 12.76 63.00 3.100 2.050
Announcement Date 4/16/19 3/30/20 3/30/21 3/21/22 4/3/23 3/8/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0777 0.0117 0.0166 0.5946 3.52 0.1221
EBITDA 1 -1.278 -1.558 -1.426 -1.823 -9.143 -8.049
EBIT 1 -1.335 -1.58 -1.44 -3.867 -13.98 -12.92
Operating Margin -1,717.2% -13,472.11% -8,696.7% -650.47% -397.09% -10,580.14%
Earnings before Tax (EBT) 1 -1.339 -1.581 -1.451 -3.889 -14.01 -13.77
Net income 1 -1.339 -1.581 -1.451 -3.889 -14.01 -13.77
Net margin -1,722.3% -13,479.65% -8,758.21% -654.04% -397.96% -11,276.98%
EPS 2 -2.817 -2.973 -2.671 -2.575 -5.135 -3.360
Free Cash Flow 1 -1.356 -0.5074 -0.5558 26.07 -24.47 0.9486
FCF margin -1,744.86% -4,324.94% -3,355.68% 4,384.31% -695.13% 776.86%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/16/19 3/30/20 3/30/21 3/21/22 4/3/23 3/8/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.04 0.93 1.87 - 3.81
Net Cash position 1 0.76 - - - 0.58 -
Leverage (Debt/EBITDA) - -0.0228 x -0.6528 x -1.025 x - -0.4731 x
Free Cash Flow 1 -1.36 -0.51 -0.56 26.1 -24.5 0.95
ROE (net income / shareholders' equity) -223% -552% 292% -83.1% -62.5% -46.6%
ROA (Net income/ Total Assets) -44.4% -95.9% -210% -11.8% -22.4% -23.4%
Assets 1 3.015 1.649 0.6904 33.05 62.48 58.79
Book Value Per Share 2 1.400 -0.2900 -1.490 5.300 8.650 5.230
Cash Flow per Share 2 2.450 0.7600 0.0400 0.9100 0.4600 0.4000
Capex 1 0 0 - 0.14 0.63 0.09
Capex / Sales 6.31% 13.96% - 24.18% 18.01% 76.15%
Announcement Date 4/16/19 3/30/20 3/30/21 3/21/22 4/3/23 3/8/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. AIMD Stock
  4. Financials Ainos, Inc.